Shanghai, 29 April 2022 – DNE Group (“DNE”), a leading new economy infrastructure investor, developer and operator in China, announced today that it has formed a joint venture (“JV Platform”) with a global institutional investor to pursue investment opportunities in life sciences parks located in top-tier cities in China, with an expected total investment of approximately US$1.2 billon.

The seed project of the JV Platform includes a high-spec core life sciences park located in ​​Shanghai Zhangjiang Sciences City, the most mature life sciences cluster in Shanghai, currently owned and operated by DNE. As the largest investment platform focusing on life sciences infrastructure in China by capital raise, the JV Platform will continue to develop and operate high-specification life sciences parks, providing best-in-class infrastructures and services for bourgeoning life sciences industry in China.

Deeply rooted in life sciences infrastructure sector, DNE is an industry-leading professional development and operating platform. It currently operates and manages life sciences parks of over 600,000 square meters in Shanghai and Yangtze River Delta region, and has over 1 million square meters pipeline projects nation-wide, providing a full range of facilities including office, R&D and production for leading international life sciences companies including WuXi AppTec, Johnson & Johnson, Zai Lab, and Junshi Pharma. To enhance its ecosystem and better serve its life sciences tenants, DNE further established DNE Capital, a private equity investment platform focusing on life sciences industry investment. DNE together with its various platforms will utilize the advantage in industry resources, infrastructure development and operation expertise to provide one-stop solutions to life sciences companies to improve their operational efficiency and achieve rapid growth.

Lingang Life Sciences Park, Shanghai

Mr. Sun Dongping, the Chairman and CEO of DNE, said, “We are pleased to partner with a leading global institutional investor with rich experiences in real estate investment. The growing pursuit of health and life quality has been flourishing life sciences industry, and therefore created booming demand for high-spec life sciences parks. DNE has been developing and investing in life sciences infrastructure since 2015, starting from the biotech hubs in Shanghai including Zhangjiang, Caohejing and Lingang area, and expanded the footprint nation-wide and built up our own competitive advantages. DNE will continue to lead in life sciences infrastructure development going forward and facilitate with the innovation and advancement of the industry.”

About DNE Group
DNE is a leading new economy infrastructure investor, developer and operator in China with over $15 billion in AUM and GFA over 12 million square meters across multiple verticals, including logistics and cold chains, life sciences and modern manufacturing parks, urban redevelopment, and data centers. DNE provides a full range of integrated infrastructure solutions to new economy clients, meeting their needs in R&D, manufacturing, warehousing and corporate headquarters. With a seasoned management team, DNE provides comprehensive capabilities spanning from acquisition, development and construction to asset and fund management. DNE aspires to deliver sustainable long-term value to its new economy clients, capital partners and stakeholders.

For more details about DNE, please visit www.dnegroup.com
Media Contact
DNE
Christy Zhang
christy.zhang@dnegroup.com